Literature DB >> 4927523

Photodynamic action of proflavine on coliphage T3. I. Kinetics of inactivation.

H Witmer, D Fraser.   

Abstract

The photodynamic inactivation of coliphage T3 was studied over a wide range of concentrations of the dye proflavine. With 2 x 10(7) phage/ml, two modes of inactivation were observed. Between 0.25 and 12 to 13 mug/ml, inactivation was biphasic. There was an initial first-order inactivation (Rx1) which became temporally associated with an apparently multiorder process (Rx2) at higher light doses. Dye concentrations above 12 to 13 mug/ml showed only two-target inactivation curves (Rx3), except at high dye concentrations where processes kinetically identical to Rx1 and Rx2 reappeared. Rx2 showed a normal rectangular hyperbolic saturation curve but Rx1 and Rx3 appeared to saturate prematurely. The saturation behavior of Rx1 and Rx2 was independent of phage concentration, but Rx3 was lost at phage titers above 2 x 10(7)/ml. No dark inactivation was seen with Rx1 and Rx2 subsequent to a period of illumination. With Rx3, an exponential dark inactivation was seen for at least 1 hr after a period of illumination. The dye-phage system equilibrated immediately, at any temperature, at proflavine concentrations where Rx1 and Rx2 occurred. With Rx3, prolonged equilibration times were necessary. Moreover, there was a temperature effect. The rate of inactivation at equilibrium was temperature-dependent, whereas the initial rate at which equilibrium was approached was essentially temperature-independent.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4927523      PMCID: PMC356120     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Photosensitization of T2 coliphage with toluidine blue.

Authors:  J J HELPRIN; C W HIATT
Journal:  J Bacteriol       Date:  1959-04       Impact factor: 3.490

2.  Studies in partially resolved bacteriophage-host systems. VII. Diamines, dyes, empty phage heads, and protoplast-infecting agent.

Authors:  D FRASER; H R MAHLER
Journal:  Biochim Biophys Acta       Date:  1961-10-14

3.  Damage by visible light to the acridine orange--DNA complex.

Authors:  D FREIFELDER; P F DAVISON; E P GEIDUSCHEK
Journal:  Biophys J       Date:  1961-05       Impact factor: 4.033

4.  Photodynamic inactivation of bacteriophage.

Authors:  J N WELSH; M H ADAMS
Journal:  J Bacteriol       Date:  1954-07       Impact factor: 3.490

5.  The amino acid composition of T3 bacteriophage.

Authors:  D FRASER; E A JERREL
Journal:  J Biol Chem       Date:  1953-11       Impact factor: 5.157

6.  Photodynamic action of proflavine on coliphage T3. 3. Damages to the deoxyribonucleic acid associated with Rxl and Rx2.

Authors:  H Witmer; D Fraser
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

7.  Mutagenesis with light and proflavine in phage T4. II. Properties of the mutants.

Authors:  D A Ritchie
Journal:  Genet Res       Date:  1965-11       Impact factor: 1.588

8.  Mechanism of photoinactivation of coliphage T-7 sensitized by acridine orange.

Authors:  D Freifelder; R B Uretz
Journal:  Virology       Date:  1966-09       Impact factor: 3.616

9.  The photodynamic action of proflavine on phage T4.

Authors:  D A Ritchie
Journal:  Biochem Biophys Res Commun       Date:  1965-09-22       Impact factor: 3.575

10.  Photodynamic action of proflavine on coliphage T3. II. Protection by L-cysteine.

Authors:  H Witmer; D Fraser
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

  10 in total
  3 in total

1.  Photodynamic action of proflavine on coliphage T3. 3. Damages to the deoxyribonucleic acid associated with Rxl and Rx2.

Authors:  H Witmer; D Fraser
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

2.  Photodynamic action of proflavine on coliphage T3. II. Protection by L-cysteine.

Authors:  H Witmer; D Fraser
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

3.  TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.

Authors:  Caterina Sagnelli; Marco Merli; Caterina Uberti-Foppa; Hamid Hasson; Anna Grandone; Grazia Cirillo; Stefania Salpietro; Carmine Minichini; Mario Starace; Emanuela Messina; Patrizia Morelli; Emanuele Miraglia Del Giudice; Adriano Lazzarin; Nicola Coppola; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.